RxDoctor Payments Data

Abbey Dichiara, NP

Nurse Practitioner · Columbus, MSNPI 1275907354

Payments from drug & device makers

$4,211in general payments, 2019–2025

Across 241 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$897
  • Boston Scientific$619
  • Merck$507
  • Johnson & Johnson$460
  • Boehringer Ingelheim$408
  • Amgen$356
  • plus $965 from 12 others

What the payments were for

  • Food & beverage$4,211100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,211 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$61,822
Medicare patients
475
Services billed
610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis24$533,292
EliquisApixaban169$114,317
EntrestoSacubitril/Valsartan92$64,389
XareltoRivaroxaban96$57,912
JardianceEmpagliflozin48$27,844
Repatha SureclickEvolocumab37$27,396
BrilintaTicagrelor45$23,259
FarxigaDapagliflozin Propanediol14$7,392
Dabigatran EtexilateDabigatran Etexilate Mesylate29$5,070
Ranolazine ErRanolazine54$3,145
Metoprolol Succinate306$2,426
Rosuvastatin Calcium196$1,381
Atorvastatin Calcium206$1,335
ClopidogrelClopidogrel Bisulfate199$1,248
Diltiazem 24hr Er (Cd)Diltiazem Hcl80$1,027

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerVyndamax, Eliquis$75$647,609193 claims
NovartisEntresto$897$64,38992 claims
Johnson & JohnsonXarelto$460$57,91296 claims
AstraZenecaBrilinta, Farxiga$272$30,65159 claims
Boehringer IngelheimJardiance$408$27,84448 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Columbus

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →